Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.

The FDA is warning patients and referrers about an imaging business near the nation’s capital that has fumbled away its mammography accreditation.

One of the largest private health insurers in the U.S. has gone from considering hybrid PET/CT for cardiac indications “experimental/investigational” to displaying willingness to pay for the modality. 

A convolutional neural network has achieved 99.67% accuracy at flagging the presence of pacemakers on chest radiographs in patients referred for MRI.

“More than most companies, Toyota is led from the bottom up as much as from the top down.”

A cancer-care technology company that was acquired by one of the world’s largest imaging OEMs a year ago has received an Investigational Device Exemption from the FDA.

Upon commissioning a business process improvement team to meticulously track interpretative uptime, a 13-radiologist group learned its members had been spending nearly as many hours navigating interruptions as reading images.

An international nonprofit medical society is teaming with a supplier of ultrasound contrast media to aid pediatric patients in Ukraine.